TRANSPLANT IMMUNOLOGY. Shiv Pillai Ragon Institute of MGH, MIT and Harvard
|
|
- Christopher Stafford
- 5 years ago
- Views:
Transcription
1 TRANSPLANT IMMUNOLOGY Shiv Pillai Ragon Institute of MGH, MIT and Harvard
2
3
4
5 Outline MHC / HLA Direct vs indirect allorecognition Alloreactive cells: where do they come from? Rejection and Immunosuppression Tolerance
6 DEFINITIONS Syngeneic: Refers to transplants betweeen genetically identical animals (I.e. identical twins, inbred strains of animals). Accept transplants from one-another without immunosuppression. Allogeneic: Transplants between animals mismatched for MHC or other histocompatibility genes, within the same species. Xenogeneic: Transplants between species.
7 People living with a functioning graft at year end
8 Genetics of solid organ transplantation
9 Inheritance and Expression of HLA genes HLA haplotype A2, B5, DR3 A1, B7, DR9 HLA haplotype A1, B24, DR14 A24, B27, DR2 HLA haplotype A2, B5, DR3 A1, B24, DR14 HLA genes are inherited as a haplotype and co-dominantly expressed
10 Why such a high precursor frequency of Alloreactive T cells? Frequency of T cells that recognize an alloantigen: Approx. 1/20 Frequency of T cells that recognize a given peptide antigen: Approx. 1/100,000-1/1,000,000
11 The TCR is generated with a bias towards MHC recognition 11
12 All DP TCRs see MHC like Shapes BEFORE selection 12
13 Thymic T cell development Downloaded from: StudentConsult (on 26 April :12 PM) 2005 Elsevier
14 Strong anti-self Weak anti-self Strong anti-allo
15
16
17 Two Types of Allorecognition
18 Two Types of Allorecognition
19 Minor antigens I have the same MHC! Minor antigens are polymorphic variants of peptides that bind the same MHC
20 Hyperacute Rejection
21 Preventing Hyperacute Rejection The Crossmatch Sera from potential recipients Donor cell + vital dye positive crossmatch + negative crossmatch
22 Acute Rejection
23 Acute Graft Rejection Induction Therapy T cell depleting: Thymoglobulin rabbit anti-thymocyte globulin CAMPATH-1H anti-cd52 Concept: 1. Many antigen-specific cells will be deleted, enabling more effective immunosuppression. 2. Possibly, the antigen-specific reconstituting cells will be educated to be regulatory T cells by the presence of the graft in a non-inflammatory environment.
24 Acute Graft Rejection Induction Therapy MHC CTLA4Ig B7 APC TCR CD28 T Cell Activation Inhibit T cell activation/block costimulation: Belatacept (modified CTLA4Ig) Concept: 1. Antigen-specific cells will be selectively rendered anergic/apoptotic because CD28 costimulation is blocked.
25 Acute Graft Rejection Induction Therapy TCR MHC Anti-CD25 APC B7 CD28 Y Growth and Survival IL-2R T Cell Targets activated T cells: Anti-CD25 mabs (basiliximab, daclizumab) Concept: 1. Blocks a key cytokine needed for cell proliferation/survival
26 Acute Graft Rejection Maintenance Therapy CD8 APC cytokines CD4 T cell expansion more cytokine production activated T lymphocytes (CTLs, DTH effectors) macrophage activation B cell maturation, antibody production
27 Acute Graft Rejection Maintenance Therapy CD8 Azathioprine Mycophenolate APC T cell expansion Belatacept Rapamycin cytokines CD4 Cyclosporine Tacrolimus activated T lymphocytes (CTLs, DTH effectors) Steroids more cytokine production macrophage activation B cell maturation, antibody production
28 Acute Rejection is not that common: Incidence of first acute rejection among adult patients receiving a kidney transplant in
29 Chronic Rejection Both T cell memory and long-lived anti-hla antibodies are a problem
30 Chronic Rejection remains a problem
31 Mechanism: cyclosporin A and FK-506
32 Early Signaling Events in T cell Activation (1) Abbas, Lichtman, and Pillai. Cellular and Molecular Immunology, 7 th edition. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
33 Early Signaling Events in T cell Activation (2) Abbas, Lichtman, and Pillai. Cellular and Molecular Immunology, 7 th edition. Copyright 2011 by Copyright Saunders, 2011 by Saunders, an imprint an imprint of of Elsevier Inc. Inc.
34 T cell Signaling Downstream of PLCg1 (1) Abbas, Lichtman, and Pillai. Cellular and Molecular Immunology, 7 th edition. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
35 T cell Signaling Downstream of PLCg1 (2) Abbas, Lichtman, and Pillai. Cellular and Molecular Immunology, 7 th edition. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
36 T cell Signaling Downstream of PLCg1 (3) Abbas, Lichtman, and Pillai. Cellular and Molecular Immunology, 7 th edition. Copyright 2011 Copyright by Saunders, 2011 by Saunders, an an imprint of of Elsevier Inc. Inc.
37 Activation of Transcription Factors in T Cells Abbas, Lichtman, and Pillai. Cellular and Molecular Immunology, 7 th edition. Copyright 2011 by Saunders, Copyright 2011 an by Saunders, imprint an imprint of Elsevier of Inc.
38 Tolerance is an obvious solution Transplantation tolerance - durable and functional persistence of a tissue, in the absence of a deleterious immune response without ongoing therapeutic intervention. MIXED CHIMERISM HAS BEEN OCCASSIONALLY SUCCESSFUL
39 Allogeneic bone-marrow transplantation to create tolerance David Sachs, Tatsuo Kawai and Ben Cosimi, MGH One-haplotype HLA mismatched living donors Kidney Transplant Donor Bone Marrow Transplant Thymic Irradiation 7 Gy Cyclophosphamide steroids CsA or Tacrolimus day 9-12 months Rituximab (anti-b cell) Anti-CD2 mab
40 Renal allograft tolerance through mixed chimerism T=0 T=2yr T=4yr T=6yr T=8yr T=0 T=2yr T=4yr Cr 1.9 mg/dl Cr 1.8 mg/dl Cr 1.6 mg/dl Cr 1.2 mg/dl Transplant IS free Post-transplant follow-up Tapering Graft loss Post-study observation All patients developed transient multi-lineage mixed chimerism, which was lost in 7 14 days Engraftment syndrome developed ~ day 10 with fever, and self limited renal dysfunction. Previously described in BMT but renal dysfunction more severe in transplanted kidneys
41
42
43 Other bone marrow/chimerism approaches Anti-thymocyte globulin, cyclophosphamide, fludaribine, low dose total body irradiation (Johns Hopkins). Similar to above plus a proprietary product called a facilitating cell (Northwestern). Anti-thymocyte globulin, hi dose total lymphoid irradiation (Stanford). Thanks to Jon Maltzman and Larry Turka
44 Cyclosporin Blues.. 44
FIT Board Review Corner March 2016
FIT Board Review Corner March 2016 Welcome to the FIT Board Review Corner, prepared by Sarah Spriet, DO, and Tammy Peng, MD, senior and junior representatives of ACAAI's Fellows-In-Training (FITs) to the
More informationAntigen Presentation and T Lymphocyte Activation. Shiv Pillai MD, PhD Massachusetts General Hospital Harvard Medical School. FOCiS
1 Antigen Presentation and T Lymphocyte Activation Shiv Pillai MD, PhD Massachusetts General Hospital Harvard Medical School FOCiS 2 Lecture outline Overview of T cell activation and the rules of adaptive
More informationTolerance Induction in Transplantation
Tolerance Induction in Transplantation Reza F. Saidi, MD, FACS, FICS Assistant Professor of Surgery Division of Organ Transplantation Department of Surgery University of Massachusetts Medical School Percent
More informationDr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION
Benjamini. Ch. 19, Pgs 379-399 Page 1 of 10 TRANSPLANTATION I. KINDS OF GRAFTS II. RELATIONSHIPS BETWEEN DONOR AND RECIPIENT Benjamini. Ch. 19, Pgs 379-399 Page 2 of 10 II.GRAFT REJECTION IS IMMUNOLOGIC
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationA Tolerance Approach to the Transplantation of Vascularized Tissues
A Tolerance Approach to the Transplantation of Vascularized Tissues The 9th New Jersey Symposium on Biomaterials Science and Regenerative Medicine October 29-31, 2008 David H. Sachs, M.D. Harvard Medical
More informationTransplantation Immunology
Transplantation Immunology Mitchell S. Cairo, MD Professor of Pediatrics, Medicine and Pathology Chief, Division, Pediatric Hematology & Blood & Marrow Transplantation Children s Hospital New York Presbyterian
More informationTransplantation Immunology
Transplantation Immunology MHC Restricted Allograft Rejection Mitchell S. Cairo, MD Professor of Pediatrics, Medicine and Pathology Chief, Division, Pediatric Hematology & Blood & Marrow Transplantation
More informationAutoimmunity & Transplantation. Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:
Autoimmunity & Transplantation Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Learning Objectives By the end of this lecture you will be able to: 1 Recognize
More informationAntigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS
1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family
More informationOverview of New Approaches to Immunosuppression in Renal Transplantation
Overview of New Approaches to Immunosuppression in Renal Transplantation Ron Shapiro, M.D. Professor of Surgery Surgical Director, Kidney/Pancreas Transplant Program Recanati/Miller Transplantation Institute
More informationImmunopathology of T cell mediated rejection
Immunopathology of T cell mediated rejection Ibrahim Batal MD Columbia University College of Physicians & Surgeons New York, NY, USA Overview Pathophysiology and grading of TCMR TCMR is still a significant
More informationT Cell Development. Xuefang Cao, MD, PhD. November 3, 2015
T Cell Development Xuefang Cao, MD, PhD November 3, 2015 Thymocytes in the cortex of the thymus Early thymocytes development Positive and negative selection Lineage commitment Exit from the thymus and
More informationIMMUNOBIOLOGY OF TRANSPLANTATION. Wasim Dar
IMMUNOBIOLOGY OF TRANSPLANTATION Wasim Dar Immunobiology of Transplantation Overview Transplantation: A complex immunologic process Contributions Innate Immunity Adaptive immunity T Cells B Cells HLA Consequences
More informationT Lymphocyte Activation and Costimulation. FOCiS. Lecture outline
1 T Lymphocyte Activation and Costimulation Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline T cell activation Costimulation, the B7:CD28 family Inhibitory receptors of T cells Targeting costimulators for
More informationImmunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells
Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells Andrew H. Lichtman, M.D. Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard
More informationShiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School
CTLs, Natural Killers and NKTs 1 Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School CTL inducing tumor apoptosis 3 Lecture outline CD8 + Cytotoxic T lymphocytes (CTL) Activation/differentiation
More informationFOCiS. Lecture outline. The immunological equilibrium: balancing lymphocyte activation and control. Immunological tolerance and immune regulation -- 1
1 Immunological tolerance and immune regulation -- 1 Abul K. Abbas UCSF FOCiS 2 Lecture outline Principles of immune regulation Self-tolerance; mechanisms of central and peripheral tolerance Inhibitory
More informationRobert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Robert B. Colvin Transplantation: Friendly organs in a hostile environment Robert B. Colvin,
More informationDeterminants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco
Determinants of Immunogenicity and Tolerance Abul K. Abbas, MD Department of Pathology University of California San Francisco EIP Symposium Feb 2016 Why do some people respond to therapeutic proteins?
More informationImmunology Lecture 4. Clinical Relevance of the Immune System
Immunology Lecture 4 The Well Patient: How innate and adaptive immune responses maintain health - 13, pg 169-181, 191-195. Immune Deficiency - 15 Autoimmunity - 16 Transplantation - 17, pg 260-270 Tumor
More informationLiver Transplant Immunosuppression
Liver Transplant Immunosuppression Michael Daily, MD, MS, FACS Surgical Director, Kidney and Pancreas Transplantation University of Kentucky Medical Center Disclosures No financial disclosures I will be
More informationTolerance 2. Regulatory T cells; why tolerance fails. FOCiS. Lecture outline. Regulatory T cells. Regulatory T cells: functions and clinical relevance
1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails
More informationXIV. HLA AND TRANSPLANTATION MEDICINE
XIV. HLA AND TRANSPLANTATION MEDICINE A. Introduction 1. The HLA system includes a complex array of genes and their molecular products that are involved in immune regulation and cellular differentiation.
More informationT Cell Activation, Costimulation and Regulation
1 T Cell Activation, Costimulation and Regulation Abul K. Abbas, MD University of California San Francisco 2 Lecture outline T cell antigen recognition and activation Costimulation, the B7:CD28 family
More information- Transplantation: removing an organ from donor and gives it to a recipient. - Graft: transplanted organ.
Immunology Lecture num. (21) Transplantation - Transplantation: removing an organ from donor and gives it to a recipient. - Graft: transplanted organ. Types of Graft (4 types): Auto Graft - From a person
More informationWhat is the Best Induction Immunosuppression Regimen in Kidney Transplantation? Richard Borrows: Queen Elizabeth Hospital Birmingham
What is the Best Induction Immunosuppression Regimen in Kidney Transplantation? Richard Borrows: Queen Elizabeth Hospital Birmingham SYMPHONY Study Ekberg et al. NEJM 2008 Excluded: DCD kidneys; CIT>30hours;
More informationTransplant Types. Basic Concepts of Transplantation Immunology. M. Sue Leffell, PhD. Professor Of Medicine & Director Immunogenetics Laboratory
Basic Concepts of Transplantation Immunology M. Sue Leffell, PhD Professor Of Medicine & Director Immunogenetics Laboratory Transplant Types Autologous (self to self) Syngeneic (identical twin to twin)
More informationPreface and Acknowledgments Preface and Acknowledgments to the Third Edition Preface to the Second Edition Preface to the First Edition
Preface and Acknowledgments p. xxi Preface and Acknowledgments to the Third Edition p. xxiii Preface to the Second Edition p. xxv Preface to the First Edition p. xxvii Acknowledgments to the First and
More informationThe role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.
The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. Robert Liwski, MD, PhD, FRCPC Medical Director HLA Typing Laboratory Department of Pathology Dalhousie
More informationClass I Ag processing. TAP= transporters associated with antigen processing Transport peptides into ER
Antigen processing Class I Ag processing TAP= transporters associated with antigen processing Transport peptides into ER Proteosome degrades cytosolic proteins Large, multi-subunit complex Degrades foreign
More information1. Discuss the basic pathophysiology of end-stage liver and kidney failure.
TRANSPLANT SURGERY ROTATION (PGY1, 2) A. Medical Knowledge Goal: The resident will achieve a detailed knowledge of the evaluation and treatment of a variety of disease processes. The resident will be exposed
More informationImmunosuppressants. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Immunosuppressants Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Immunosuppressive Agents Very useful in minimizing the occurrence of exaggerated or inappropriate
More informationUNIVERSITAT DE BARCELONA IMMUNE PROFILING OF OPERATIONAL TOLERANCE IN LIVER TRANSPLANTATION
UNIVERSITAT DE BARCELONA Faculty of Medicine IMMUNE PROFILING OF OPERATIONAL TOLERANCE IN LIVER TRANSPLANTATION Thesis presented by Marc Martínez Llordella to obtain the degree of Doctor in Biology This
More informationTransplant Booklet D Page 1
Booklet D Pretest Correct Answers 4. (A) is correct. Technically, performing a hematopoietic stem cell transplant is one of the simplest transplantation procedures. The hematopoietic stem cells are infused
More informationTolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF
Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells
More informationEffector T Cells and
1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New
More informationMECHANISMS OF CELLULAR REJECTION IN ORGAN TRANSPLANTATION AN OVERVIEW
MECHANISMS OF CELLULAR REJECTION IN ORGAN TRANSPLANTATION AN OVERVIEW YVON LEBRANCHU Service Néphrologie et Immunologie Clinique CHU TOURS ANTIGEN PRESENTING CELL CD4 + T CELL CYTOKINE PRODUCTION CLONAL
More informationOBJECTIVES. Phases of Transplantation and Immunosuppression
Transplant and Immunosuppression: Texas Transplant Center April 29, 2017 Regina L. Ramirez, Pharm.D., BCPS PGY1 Pharmacy Residency Program Director Clinical Practice Specialist Solid Organ Transplant and
More informationSolid Organ Transplantation 1. Chapter 55. Solid Organ Transplant, Self-Assessment Questions
Solid Organ Transplantation 1 Chapter 55. Solid Organ Transplant, Self-Assessment Questions Questions 1 to 9 are related to the following case: A 38-year-old white man is scheduled to receive a living-unrelated
More informationHLA, tra immunità innata e adattativa
HLA, tra immunità innata e adattativa Emanuele Cozzi S.S.D. Immunologia dei Trapianti Azienda Ospedaliera di Padova Punti della presentazione Risultati attuali del trapianto e problematiche aperte Immunità
More informationBasic Immunology. Cytokines, cytokine receptors. Lecture 8th. Timea Berki MD, PhD
Basic Immunology Lecture 8th Cytokines, cytokine receptors Timea Berki MD, PhD 1. By direct cell-cell interactions: through adhesion molecules 2. By low MW regulatory proteins, called cytokines: messengers
More informationCellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU
Cellular Immune response Jianzhong Chen, Ph.D Institute of immunology, ZJU Concept of adaptive immune response T cell-mediated adaptive immune response I. Concept of immune response A collective and coordinated
More informationInnovation In Transplantation:
Innovation In Transplantation: Improving outcomes Thomas C. Pearson Department of Surgery Emory Transplant Center CHOA Symposium October 22, 2016 Disclosures Belatacept preclinical and clinical trial were
More informationEfficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function
ArtIcle Efficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function Guodong Chen, 1 Jingli Gu, 2 Jiang Qiu, 1 Changxi
More informationAntigen capture and presentation to T lymphocytes
Antigen capture and presentation to T lymphocytes What T lymphocytes see Innate Immunity Immediately available or Very broad specificity rapidly recruited Adaptive Immunity Rare and naïve cells require
More informationImmunosuppressive therapy for graft-versus-host disease. Mohamad Mohty Institut Paoli-Calmettes, Marseille
Immunosuppressive therapy for graft-versus-host disease Mohamad Mohty Institut Paoli-Calmettes, Marseille Survival according to GVHD grade (Joint SFGM-TC, DFCI and IBMTR data; N=607) Cahn et al., Blood
More informationSEVENTH EDITION CHAPTER
Judy Owen Jenni Punt Sharon Stranford Kuby Immunology SEVENTH EDITION CHAPTER 16 Tolerance, Autoimmunity, and Transplantation Copyright 2013 by W. H. Freeman and Company Immune tolerance: history * Some
More informationTransplantation immunology: Solid organ and bone marrow
Transplantation immunology: Solid organ and bone marrow Javier Chinen, MD, PhD, a and Rebecca H. Buckley, MD b Houston, Tex, and Durham, NC Development of the field of organ and tissue transplantation
More informationIMMUNOGENETICS AND TRANSPLANTATION
IMMUNOGENETICS AND TRANSPLANTATION WHAT S THE MHC GOT TO DO WITH TRANSPLANTATION? We have learned that the molecules of Class I and II MHC are involved in presenting antigenic peptides to the receptors
More informationEffector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells
ICI Basic Immunology course Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells Abul K. Abbas, MD UCSF Stages in the development of T cell responses: induction
More informationLecture outline. Immunological tolerance and immune regulation. Central and peripheral tolerance. Inhibitory receptors of T cells. Regulatory T cells
1 Immunological tolerance and immune regulation Abul K. Abbas UCSF 2 Lecture outline Central and peripheral tolerance Inhibitory receptors of T cells Regulatory T cells 1 The immunological equilibrium:
More informationIntroduction. University School of Medicine, Stanford, CA. Received 19 June 2014, revised 03 October 2014 and accepted for publication 04 October 2014
American Journal of Transplantation 15; 15: 695 74 Wiley Periodicals Inc. C Copyright 15 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 1.1111/ajt.1391 Chimerism,
More informationIMMUNOGENETICS AND INTRODUCTION TO TRANSPLANTATION
IMMUNOGENETICS AND INTRODUCTION TO TRANSPLANTATION WHAT S THE MHC GOT TO DO WITH TRANSPLANTATION? We have learned that Class I and II MHC are involved in presenting antigenic peptides to the receptors
More informationComposite Tissue Allotransplantation Immunology
CONTINUING MEDICAL EDUCATION Composite Tissue Allotransplantation Immunology Seok Chan Eun Department of Plastic and Reconstructive Surgery, Seoul National University Bundang Hospital, Seoul National University
More information5/1/13. The proportion of thymus that produces T cells decreases with age. The cellular organization of the thymus
T cell precursors migrate from the bone marrow via the blood to the thymus to mature 1 2 The cellular organization of the thymus The proportion of thymus that produces T cells decreases with age 3 4 1
More informationT Cell Development II: Positive and Negative Selection
T Cell Development II: Positive and Negative Selection 8 88 The two phases of thymic development: - production of T cell receptors for antigen, by rearrangement of the TCR genes CD4 - selection of T cells
More informationMucosal Immune System
Exam Format 100 points - 60 pts mandatory; 40 points where 4, 10 point questions will be chosen Some open-ended questions, some short answer. Kuby question Cytokines Terminology How do cytokines achieve
More informationBetter than Google- Click on Immunosuppression Renal Transplant. David Landsberg Oct
Better than Google- Click on Immunosuppression Renal Transplant David Landsberg Oct 3 2008 OUTLINE History of Immunosuppression Trends in Immunosupression FK vs CYA Steroid Minimization CNI Avoidance Sirolimus
More informationIntroduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018
Introduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018 The transfer of hematopoietic progenitor and stem cells for therapeutic purposes Hematopoietic Cell
More informationPost-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies
Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies Lorita M Rebellato, Ph.D., D (ABHI) Associate Professor Department of Pathology The Brody School of Medicine at ECU Scientific
More informationSignificance of human leukocyte antigens in immunobiology of renal transplantation
Significance of human leukocyte antigens in immunobiology of renal transplantation Suraksha Agrawal*, Avneesh Kumar Singh and Uddalak Bharadwaj Department of Genetics, Sanjay Gandhi Post-Graduate Institute
More informationBelatacept: An Opportunity to Personalize Immunosuppression? Andrew Adams MD/PhD Emory Transplant Center
Belatacept: An Opportunity to Personalize Immunosuppression? Andrew Adams MD/PhD Emory Transplant Center Disclosure Research Funding from BMS. Learning Objectives -Define belatacept-resistant rejection
More informationSummary of T32 Research Joshua Weiner June 2015
Summary of T32 Research Joshua Weiner June 2015 Project 1: Regulatory T Cell (Treg) Expansion Xenotransplantation could help make up the difference in the numbers of organs needed for transplantation and
More informationSolid Organ Transplantation
Solid Organ Transplantation Ronald H. Kerman, PhD Professor of Surgery Director, Histocompatibility and Immune Evaluation Laboratory Division of Immunology & Organ Transplantation The University of Texas
More informationSerum samples from recipients were obtained within 48 hours before transplantation. Pre-transplant
SDC, Patients and Methods Complement-dependent lymphocytotoxic crossmatch test () Serum samples from recipients were obtained within 48 hours before transplantation. Pre-transplant donor-specific CXM was
More information("T-Lymphocytes, Regulatory"[Mesh]) AND "Immunosuppression"[Mesh] ("T-Lymphocytes, Regulatory"[Mesh]) AND "Immunosuppressive Agents"[Mesh]
SEARCH STRATEGY PubMed: ("T-Lymphocytes, Regulatory"[Mesh]) AND "Immunosuppression"[Mesh] ("T-Lymphocytes, Regulatory"[Mesh]) AND "Immunosuppressive Agents"[Mesh] ("T-Lymphocytes, Regulatory"[Mesh]) AND
More informationFellows Conference 01/21/2016
Fellows Conference 01/21/2016 Outline Basics of transplantation Benefits of transplantation Immunosuppressive medications Anatomy of Renal Transplantation Recipient Selection General medical condition.
More informationThis study is currently recruiting participants.
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation This study is currently recruiting
More informationHaploidentical Transplantation today: and the alternatives
Haploidentical Transplantation today: and the alternatives Daniel Weisdorf MD University of Minnesota February, 2013 No matched sib: where to look? URD donor requires close HLA matching and 3-12 weeks
More informationTransplant Applications of Solid phase Immunoassays Anti HLA antibody testing in solid organ transplantation
AACC Professional Course BETH ISRAEL DEACONESS MEDICAL CENTER HARVARD MEDICAL SCHOOL Transplant Applications of Solid phase Immunoassays Anti HLA antibody testing in solid organ transplantation J. Ryan
More informationTolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS
1 Tolerance 2. Regulatory T cells; why tolerance fails Abul K. Abbas UCSF FOCiS 2 Lecture outline Regulatory T cells: functions and clinical relevance Pathogenesis of autoimmunity: why selftolerance fails
More informationOne Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases
One Day BMT Course by Thai Society of Hematology Management of Graft Failure and Relapsed Diseases Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital
More informationBasel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva
Basel - 6 eptember 2012 J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva Outline the HLA system is (a) complex anti-hla immunisation and alloreactivity
More informationCase 54. Cell-Mediated Immunity. Thought Questions. Basic Science Review and Discussion
Part_II-Gandhi 6/24/03 10:48 AM Page 161 HPI: IL is a 45-year-old diabetic man who had a kidney transplant 2 weeks ago. IL now presents with shortness of breath, severe hypertension, rapid weight gain,
More informationReview of Rituximab and renal transplantation. Dr.E Nemati. Professor of Nephrology
Review of Rituximab and renal transplantation Dr.E Nemati Professor of Nephrology Introductio n Rituximab is a chimeric anti-cd20 monoclonal antibody. The CD20 antigen is a transmembrane nonglycosylated
More informationThe development of T cells in the thymus
T cells rearrange their receptors in the thymus whereas B cells do so in the bone marrow. The development of T cells in the thymus The lobular/cellular organization of the thymus Immature cells are called
More informationAlloreattività e Tolleranza nei Trapianti di Cellule Staminali Emopoietiche Allogeniche
Alloreattività e Tolleranza nei Trapianti di Cellule Staminali Emopoietiche Allogeniche Massimo Fabrizio Martelli Ematologia ed Immunologia Clinica Università degli Studi di Perugia 41 Congresso Nazionale
More informationASSESSMENT OF THE PAEDIATRIC NEEDS IMMUNOLOGY DISCLAIMER
European Medicines Agency Evaluation of Medicines for Human Use London, September 2006 Doc. Ref.: EMEA/381922/2006 ASSESSMENT OF THE PAEDIATRIC NEEDS IMMUNOLOGY DISCLAIMER The Paediatric Working Party
More informationPUO in the Immunocompromised Host: CMV and beyond
PUO in the Immunocompromised Host: CMV and beyond PUO in the immunocompromised host: role of viral infections Nature of host defect T cell defects Underlying disease Treatment Nature of clinical presentation
More informationImmunology. Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency
Immunology Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency Transplant Immunology Transplantation is the process of moving cells, tissues or organs from one site to another
More informationE possibile creare un ambiente tollerogenico dopo il trapianto d organo utilizzando cellule staminali come se fossero farmaci?
E possibile creare un ambiente tollerogenico dopo il trapianto d organo utilizzando cellule staminali come se fossero farmaci? Giuseppe Remuzzi 1 Infections & Transplantation Varese, 18 maggio 2017 LONG
More informationREVIEWS. Mesenchymal stromal cells in renal transplantation: opportunities and challenges
Mesenchymal stromal cells in renal transplantation: opportunities and challenges Federica Casiraghi 1, Norberto Perico 2, Monica Cortinovis 1 and Giuseppe Remuzzi 2 Abstract Lifelong immunosuppressive
More informationRegulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo
Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo See related Commentary on pages 797 798 Ana Maria Waaga, 1,2 Martin Gasser, 1 Joana E. Kist-van Holthe, 2 Nader
More informationLESSON 2: THE ADAPTIVE IMMUNITY
Introduction to immunology. LESSON 2: THE ADAPTIVE IMMUNITY Today we will get to know: The adaptive immunity T- and B-cells Antigens and their recognition How T-cells work 1 The adaptive immunity Unlike
More informationKavita Raj Consultant Haematologist KHP
Kavita Raj Consultant Haematologist KHP 1950s Billingham and Brent injection of spleen cells from adult mice into newborn mice Thickening and loss elasticity of skin, red soles, exfoliation, diarrhoea
More informationStrategies for Desensitization
Strategies for Desensitization Olwyn Johnston MB, MRCPI, MD, MHSc BC Nephrology Day October 8 th 2010 Pre-transplant crossmatch (CMX) with donor lymphocytes has been standard of practice Positive CDC CXM
More informationT Cell Differentiation
T Cell Differentiation Ned Braunstein, MD MHC control of Immune Responsiveness: Concept Whether or not an individual makes an immune response to a particular antigen depends on what MHC alleles an individual
More informationChapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group
FIT Board Review Corner September 2015 Welcome to the FIT Board Review Corner, prepared by Andrew Nickels, MD, and Sarah Spriet, DO, senior and junior representatives of ACAAI's Fellows-In-Training (FITs)
More informationObjectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions
Objectives Abbas Chapter 11: Immunological Tolerance Christina Ciaccio, MD Children s Mercy Hospitals and Clinics February 1, 2010 To introduce the concept of immunologic tolerance To understand what factors
More informationImmunology. Teamwork 437. Lecture (3): Cell Mediated Immunity. Color index: IMPORTANT Definition Explanations + notes Extra (or gray)
IMMUNOLOGY TEAM 437 Immunology Teamwork 437 Lecture (3): Cell Mediated Immunity Color index: IMPORTANT Definition Explanations + notes Extra (or gray) Objectives To describe antigen recognition by T cells.
More informationDefensive mechanisms include :
Acquired Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated immunity Humoral immunity Two mechanisms 1) Humoral
More informationTumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School
Tumor Immunity and Immunotherapy Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School Lecture Outline Evidence for tumor immunity Types of tumor antigens Generation of anti-tumor
More informationTransplantation in Australia and New Zealand
Transplantation in Australia and New Zealand Matthew D. Jose MBBS (Adel), FRACP, FASN, PhD (Monash), AFRACMA Professor of Medicine, UTAS Renal Physician, Royal Hobart Hospital Overview CKD in Australia
More informationHematopoietic Stem Cells, Stem Cell Processing, and Transplantation
Hematopoietic Stem Cells, Stem Cell Processing, and Joseph (Yossi) Schwartz, M irector, Hemotherapy and Stem Cell Processing Facility Bone Marrow Can Cure: Leukemia Lymphoma Multiple Myeloma Genetic iseases:
More informationSignificance of the MHC
CHAPTER 7 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationPharmacology notes Interleukin-2 receptor-blocking monoclonal antibodies: evaluation of 2 new agents
BUMC Proceedings 1999;12:110-112 Pharmacology notes Interleukin-2 receptor-blocking monoclonal antibodies: evaluation of 2 new agents CHERYLE GURK-TURNER, RPH Department of Pharmacy Services, BUMC wo mouse/human
More informationChronic Kidney Disease & Transplantation. Paediatrics : 2004 FRACP
Chronic Kidney Disease & Transplantation Paediatrics : 2004 FRACP ANZDATA Registry Mode of First Treatment - Paediatric 14 12 10 8 6 4 2 0 0-4 y 5-9 y 10-14 y 15-19 y Hospital CAPD Hospital HD Hospital
More informationCellular Pathology of immunological disorders
Cellular Pathology of immunological disorders SCBM344 Cellular and Molecular Pathology Witchuda Payuhakrit, Ph.D (Pathobiology) witchuda.pay@mahidol.ac.th Objectives Describe the etiology of immunological
More informationIntruduction PSI MODE OF ACTION AND PHARMACOKINETICS
Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation Andreas Zuckermann, MD et al. Department of Cardio-Thoracic Surgery, Medical University
More information